Isorhamnetin mainly affects Nrf2/Keap1 pathway and significantly alleviates the inflammatory response in chronic obstructive pulmonary disease (COPD) mice (Xu et al., 2022b). The gene discussed is KEAP1; the disease is chronic obstructive pulmonary disease.